AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32308115 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine volume measurement
Number of subjects: 815
Study 32308115 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ovarian volume measurement
Number of subjects: 815
Study 32308115 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ovarian volume measurement
Number of subjects: 815
Study 32308115 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial thickness measurement
Number of subjects: 815
Study 32308115 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of ultrasound-detected gynecological pathology
Number of subjects: 815
Study 33155565 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip arthrography
Number of subjects: 47
Study 34791007 — intervention group
Group type: EXPERIMENTAL
Intervention: Camelina oil (1.5 g ALA/d)
Number of subjects: 81
Study 34791007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 33706617 — intervention group
Group type: EXPERIMENTAL
Intervention: BladderScan feedback method
Number of subjects: 11
Study 33706617 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 11
Study 34852677 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate mobilization with a removable forearm splint for one week and active supervised group physiotherapy and home exercises from the first postoperative day.
Number of subjects: 116
Study 34852677 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate mobilization group
Number of subjects: 116
Study 34852677 — intervention group
Group type: COMPARATOR
Intervention: Cast immobilization group
Number of subjects: 116
Study 34852677 — intervention group
Group type: COMPARATOR
Intervention: Immediate mobilization group and Cast immobilization group
Number of subjects: 116
Study 35403537 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate sedation
Number of subjects: 470
Study 35403537 — intervention group
Group type: COMPARATOR
Intervention: Deep sedation
Number of subjects: 470
Study 32346190 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-based soap + alcohol-based chlorhexidine (CSAC)
Number of subjects: 170
Study 32346190 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-based soap + 70% ethyl alcohol + alcohol-based chlorhexidine (CSAAC)
Number of subjects: 170
Study 34627672 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week early moderate-intensity resistance training
Number of subjects: 31
Study 34627672 — intervention group
Group type: COMPARATOR
Intervention: Aerobic-based rehabilitation (control)
Number of subjects: 31
Study 33221618 — intervention group
Group type: EXPERIMENTAL
Intervention: New C-arm system with improved hardware and optimized image processing algorithms
Number of subjects: 49
Study 33221618 — intervention group
Group type: COMPARATOR
Intervention: Conventional angiography unit B
Number of subjects: 49
Study 32706428 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone Replacement Therapy (TRT) for 6 months
Number of subjects: 60
Study 32706428 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TRT)
Number of subjects: 60
Study 35732555 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia with short sleep duration (ISSD)
Number of subjects: 1741
Study 35732555 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia with normal sleep duration (INSD)
Number of subjects: 1741
Study 35732555 — intervention group
Group type: COMPARATOR
Intervention: Normal sleepers (≥6 hours)
Number of subjects: 1741
Study 34699271 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral surgery (TOS) plus 50 Gy postoperative radiation therapy (RT)
Number of subjects: 495
Study 34699271 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral surgery (TOS) plus 60 Gy postoperative radiation therapy (RT)
Number of subjects: 495
Study 34699271 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral surgery (TOS) plus 66 Gy RT and weekly cisplatin
Number of subjects: 495
Study 34699271 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral surgery (TOS) with observation
Number of subjects: 495
Study 34699271 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional assessment of cancer therapy-head and neck
Number of subjects: 495
Study 33896813 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat rehabilitation guidance
Number of subjects: 0
Study 33896813 — intervention group
Group type: COMPARATOR
Intervention: Conventional discharge guidance
Number of subjects: 0
Study 35979216 — intervention group
Group type: EXPERIMENTAL
Intervention: Jinhua Qinggan granules (JHQG)
Number of subjects: 300
Study 35979216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 34349267 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop insulin therapy (using faster insulin aspart)
Number of subjects: 26
Study 34349267 — intervention group
Group type: COMPARATOR
Intervention: Standard insulin therapy (control)
Number of subjects: 26
Study 34349267 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop insulin therapy
Number of subjects: 26
Study 32194001 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Physical Activity Program
Number of subjects: 40
Study 32194001 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Training (FT)
Number of subjects: 40
Study 34508882 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol 0.5 μg daily for 14 days
Number of subjects: 50
Study 34508882 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 50
Study 35155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Group counselling with spiritual content in eight sessions at 16 to 20 weeks of gestation
Number of subjects: 40
Study 35155674 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 40
Study 35155674 — intervention group
Group type: EXPERIMENTAL
Intervention: Group counselling with spiritual content
Number of subjects: 40
Study 33446071 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Video Game (AVG) training for 40 minutes
Number of subjects: 29
Study 33446071 — intervention group
Group type: COMPARATOR
Intervention: Non-AVG training for 40 minutes
Number of subjects: 29
Study 33446071 — intervention group
Group type: EXPERIMENTAL
Intervention: Both AVG and non-AVG groups
Number of subjects: 29
Study 33446071 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced AVG players
Number of subjects: 29
Study 33109532 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-Family Partnership (NFP) plus existing services
Number of subjects: 739
Study 33109532 — intervention group
Group type: COMPARATOR
Intervention: Existing services
Number of subjects: 739
Study 35467938 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 149
Study 35467938 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 149
Study 33436700 — intervention group
Group type: EXPERIMENTAL
Intervention: Traction suture at the corneal limbus (CS)
Number of subjects: 41
Study 33436700 — intervention group
Group type: COMPARATOR
Intervention: Superior rectus muscle suture (MS)
Number of subjects: 41
Study 33838357 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (DDAVP) at a maximum dose of 0.2 micrograms per kg
Number of subjects: 44
Study 33838357 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control) injected 30 min before surgery
Number of subjects: 44
Study 33838357 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (DDAVP)
Number of subjects: 44
Study 33838357 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 44
Study 33438009 — intervention group
Group type: EXPERIMENTAL
Intervention: Low added sugar intake (0 g/d)
Number of subjects: 12
Study 33438009 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium added sugar intake (75 g/d)
Number of subjects: 12
Study 33438009 — intervention group
Group type: EXPERIMENTAL
Intervention: High added sugar intake (150 g/d)
Number of subjects: 12
Study 33438009 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake at lunch and low intake at breakfast
Number of subjects: 12
Study 33438009 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline fasting breath CIR
Number of subjects: 12
Study 32360142 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminosidine (15 mg/kg, subcutaneously, once daily, for 28 days) and allopurinol (10 mg/kg, per os, twice daily, for 6 months)
Number of subjects: 40
Study 32360142 — intervention group
Group type: COMPARATOR
Intervention: Meglumine antimoniate (100 mg/kg SC, once daily, for 28 days) and allopurinol (10 mg/kg, per os, twice daily, for 6 months)
Number of subjects: 40
Study 32360142 — intervention group
Group type: COMPARATOR
Intervention: Meglumine antimoniate-allopurinol combination
Number of subjects: 40
Study 32360142 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminosidine-allopurinol combination
Number of subjects: 40
Study 34906572 — intervention group
Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 97
Study 34906572 — intervention group
Group type: COMPARATOR
Intervention: Neutral control condition
Number of subjects: 97
Study 34763774 — intervention group
Group type: COMPARATOR
Intervention: 1-year DAPT
Number of subjects: 15083
Study 34763774 — intervention group
Group type: EXPERIMENTAL
Intervention: ≤6-month DAPT
Number of subjects: 15083
Study 33885035 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (n=75)
Number of subjects: 27
Study 33885035 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream (n=77)
Number of subjects: 27
Study 32285282 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief educational intervention on multi-modal pain control
Number of subjects: 100
Study 32285282 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 100
Study 35147086 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg Liriope platyphylla extract
Number of subjects: 0
Study 35147086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33946101 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily text messages sent via WhatsApp during the study period (group 1)
Number of subjects: 44
Study 33946101 — intervention group
Group type: COMPARATOR
Intervention: No text messages received (control group, group 2)
Number of subjects: 44
Study 32583727 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic fitness test performed prior to memory test
Number of subjects: 0
Study 32583727 — intervention group
Group type: COMPARATOR
Intervention: Aerobic fitness test performed after memory test
Number of subjects: 0
Study 35772861 — intervention group
Group type: EXPERIMENTAL
Intervention: atrasentan 0.75 mg/day
Number of subjects: 3668
Study 35772861 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 3668
Study 33878853 — intervention group
Group type: COMPARATOR
Intervention: Poorly-controlled group (PC) - HbA1c > 7.5%
Number of subjects: 50
Study 33878853 — intervention group
Group type: COMPARATOR
Intervention: Well-controlled group (WC) - HbA1c ≤ 7.5%
Number of subjects: 50
Study 33878853 — intervention group
Group type: COMPARATOR
Intervention: Poorly-controlled group (PC)
Number of subjects: 50
Study 35120593 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial shunt device
Number of subjects: 1072
Study 35120593 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 1072
Study 34583306 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification for Interpretations (CBM-I)
Number of subjects: 71
Study 34583306 — intervention group
Group type: COMPARATOR
Intervention: Active control training
Number of subjects: 71
Study 36054166 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical methotrexate 1% gel (MTX)
Number of subjects: 40
Study 36054166 — intervention group
Group type: COMPARATOR
Intervention: Topical calcipotriol 0.005% cream (CPL)
Number of subjects: 40
Study 32512234 — intervention group
Group type: EXPERIMENTAL
Intervention: O2‐Suppl (100%)
Number of subjects: 11
Study 32536213 — intervention group
Group type: EXPERIMENTAL
Intervention: FLASH sexual health education curriculum
Number of subjects: 222
Study 32080218 — intervention group
Group type: EXPERIMENTAL
Intervention: GumChucks
Number of subjects: 40
Study 32080218 — intervention group
Group type: COMPARATOR
Intervention: String Floss (SF)
Number of subjects: 40
Study 34600798 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional group (surgical intervention triggered by CM drop)
Number of subjects: 60
Study 34600798 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 34600798 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with no CM drop during insertion
Number of subjects: 60
Study 34600798 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with recovered CM after initial drop
Number of subjects: 60
Study 34600798 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CM drop during insertion
Number of subjects: 60
Study 34535158 — intervention group
Group type: EXPERIMENTAL
Intervention: Early awake prone positioning (APP) initiated within 24 hours of high-flow nasal cannula (HFNC) start
Number of subjects: 125
Study 34535158 — intervention group
Group type: COMPARATOR
Intervention: Late awake prone positioning (APP) initiated after 24 hours of high-flow nasal cannula (HFNC) start
Number of subjects: 125
Study 32938723 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical surgery including pelvic and para-aortic lymphadenectomy and subsequent platinum-based chemotherapy
Number of subjects: 495
Study 32938723 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphadenectomy
Number of subjects: 495
Study 32938723 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexually active patients
Number of subjects: 495
Study 32938723 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexually inactive patients
Number of subjects: 495
Study 32938723 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patient responses
Number of subjects: 495
Study 34110455 — intervention group
Group type: EXPERIMENTAL
Intervention: Anteriorly pedicled osteoplastic flap for mastoid closure (Case group)
Number of subjects: 126
Study 34110455 — intervention group
Group type: COMPARATOR
Intervention: Traditional periosteal flap (Control group)
Number of subjects: 126
Study 33217063 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergic asthma
Number of subjects: 1984
Study 33217063 — intervention group
Group type: EXPERIMENTAL
Intervention: Eosinophilic asthma
Number of subjects: 1984
Study 33217063 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 asthma
Number of subjects: 1984
Study 33372122 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT
Number of subjects: 289
Study 33372122 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 289
Study 32817407 — intervention group
Group type: EXPERIMENTAL
Intervention: PIB with 0.2% ropivacaine (group 2, n=27)
Number of subjects: 50
Study 32817407 — intervention group
Group type: COMPARATOR
Intervention: PIB with saline infusion (group 1, n=23)
Number of subjects: 50
Study 35391838 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 192
Study 35391838 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 192
Study 35178371 — intervention group
Group type: EXPERIMENTAL
Intervention: Faith-Based Interventions (FBIs)
Number of subjects: 0
Study 35178371 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support and religiosity
Number of subjects: 0
Study 35178371 — intervention group
Group type: EXPERIMENTAL
Intervention: Types of FBI
Number of subjects: 0
Study 35178371 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study 616191460 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet (FBT) given prophylactically at 20-50% of daily dose
Number of subjects: 0
Study 616191460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36189733 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative adductor canal block (ACB)
Number of subjects: 50
Study 36189733 — intervention group
Group type: COMPARATOR
Intervention: Postoperative adductor canal block (ACB)
Number of subjects: 50
Study 33368570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 172
Study 33368570 — intervention group
Group type: COMPARATOR
Intervention: Sham cryotherapy
Number of subjects: 172
Study 32480361 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation (HBR) system using smartwatch and smartphone app
Number of subjects: 23
Study 32480361 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 23
Study 36150070 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened for STI during pregnancy (n=3483)
Number of subjects: 4553
Study 36150070 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of positive STI test
Number of subjects: 4553
Study 33961343 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic Stable Intramedullary Nailing (ESIN)
Number of subjects: 350
Study 33961343 — intervention group
Group type: COMPARATOR
Intervention: Metal Plate Internal Fixation (MPIF)
Number of subjects: 350
Study 32113613 — intervention group
Group type: EXPERIMENTAL
Intervention: Music tuned to 440 Hz
Number of subjects: 0
Study 32113613 — intervention group
Group type: COMPARATOR
Intervention: Music tuned to 432 Hz
Number of subjects: 0
Study 35779695 — intervention group
Group type: EXPERIMENTAL
Intervention: Test I (additional 40 minutes of outdoor time)
Number of subjects: 6295
Study 35779695 — intervention group
Group type: EXPERIMENTAL
Intervention: Test II (additional 80 minutes of outdoor time)
Number of subjects: 6295
Study 35779695 — intervention group
Group type: COMPARATOR
Intervention: Control (habitual outdoor time)
Number of subjects: 6295
Study 33637220 — intervention group
Group type: COMPARATOR
Intervention: Conventional amplification strategy
Number of subjects: 39
Study 33637220 — intervention group
Group type: EXPERIMENTAL
Intervention: Notch filter amplification strategy
Number of subjects: 39
Study 33235439 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg nebivolol plus 20 mg rosuvastatin (NEBI/RSV)
Number of subjects: 276
Study 33235439 — intervention group
Group type: COMPARATOR
Intervention: 5 mg nebivolol (NEBI)
Number of subjects: 276
Study 33235439 — intervention group
Group type: COMPARATOR
Intervention: 20 mg rosuvastatin (RSV)
Number of subjects: 276
Study 35090411 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP-PUF intervention
Number of subjects: 900
Study 32539663 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg weight-based dosing (to a maximum of 200 mg)
Number of subjects: 384
Study 32539663 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat dosing of 200 mg
Number of subjects: 384
Study 32539663 — intervention group
Group type: EXPERIMENTAL
Intervention: Vial sharing using 100 mg vials
Number of subjects: 384
Study 32539663 — intervention group
Group type: EXPERIMENTAL
Intervention: Vial sharing practices
Number of subjects: 384
Study 36424267 — intervention group
Group type: EXPERIMENTAL
Intervention: FEMT
Number of subjects: 35
Study 36424267 — intervention group
Group type: EXPERIMENTAL
Intervention: WAMT
Number of subjects: 35
Study 34697965 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (30 mg BID) during week 1, switched to placebo during weeks 2-3, placebo during week 4
Number of subjects: 34
Study 34697965 — intervention group
Group type: COMPARATOR
Intervention: Placebo during weeks 2-3 and week 4
Number of subjects: 34
Study 35137696 — intervention group
Group type: EXPERIMENTAL
Intervention: ClearVisc
Number of subjects: 372
Study 35137696 — intervention group
Group type: COMPARATOR
Intervention: Viscoat
Number of subjects: 372
Study 36309966 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose amitriptyline (10–20 mg based on self‐titration)
Number of subjects: 752
Study 32282044 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention (ENABLE CHF-PC) consisting of four weekly psychosocial and problem-solving support telephonic sessions lasting 20-60 minutes facilitated by a trained nurse coach plus monthly follow-up for 48 weeks.
Number of subjects: 158
Study 32282044 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no additional intervention)
Number of subjects: 158
Study 32282044 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention (ENABLE CHF-PC)
Number of subjects: 158
Study 35908130 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizoribine (MZR), n = 25
Number of subjects: 58
Study 35908130 — intervention group
Group type: COMPARATOR
Intervention: Control, n = 28
Number of subjects: 58
Study 34979571 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly video consultations plus regular care (IG)
Number of subjects: 240
Study 34979571 — intervention group
Group type: COMPARATOR
Intervention: Regular care only (WG)
Number of subjects: 240
Study 34747448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ansofaxine 40 mg/d
Number of subjects: 255
Study 34747448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ansofaxine 80 mg/d
Number of subjects: 255
Study 34747448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ansofaxine 120 mg/d
Number of subjects: 255
Study 34747448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ansofaxine 160 mg/d
Number of subjects: 255
Study 34747448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 35372992 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose IV iron administered proactively
Number of subjects: 2141
Study 35372992 — intervention group
Group type: COMPARATOR
Intervention: Low-dose IV iron administered reactively
Number of subjects: 2141
Study 36101805 — intervention group
Group type: EXPERIMENTAL
Intervention: Qinfan decoction combined with VSD
Number of subjects: 69
Study 36101805 — intervention group
Group type: COMPARATOR
Intervention: VSD
Number of subjects: 69
Study 35363812 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue Group (shoulder fatigue protocol with dominant arm)
Number of subjects: 40
Study 35363812 — intervention group
Group type: COMPARATOR
Intervention: Control Group (10-minute break)
Number of subjects: 40
Study 35363812 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue Group
Number of subjects: 40
Study 35363812 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 40
Study 34184057 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3730